OR7E94P

Across TCGA pan-cancer cohorts, OR7E94P RNA differs between tumor and matched normal tissue in 12 of 18 cancer types tested, making tumor–normal expression one of OR7E94P’s most consistent transcriptional readouts.

The strongest signal is observed in bladder urothelial carcinoma (BLCA), where OR7E94P RNA is repressed in tumor relative to normal tissue. In most cancer types OR7E94P is over-expressed in tumor, although a few such as BLCA and LUSC show the opposite, repressed pattern.

BLCA, KIRC, and LUSC are the cancer types where OR7E94P tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in OR7E94P RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
BLCA	All	All	−0.192	<.001	11	view →
KIRC	Female	All	+0.321	<.001	9	view →
LUSC	Female	All	−0.429	<.001	8	view →
LUAD	All	All	−0.127	.001	7	view →
COAD	All	All	−0.105	<.001	7	view →
BRCA	All	II,III,IV	−0.143	<.001	4	view →
KICH	Male	All	−0.134	.001	4	view →
LIHC	Female	All	+0.030	.011	4	view →
THCA	All	IV	−0.265	.015	2	view →
STAD	All	All	−0.211	.014	2	view →
UCEC	All	All	−0.204	.001	2	view →
READ	All	All	−0.160	.008	2	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 12 strongest of 12 lineages.

OR7E94P–BLCA

Open the BLCA breakdown →